Covid-19 roundup: An old, cheap steroid proves to be a major boon to coronavirus patients; BARDA puts $85M behind Regeneron antibody effort
Researchers today spotlighted data from a clinical study offering the first hard evidence that a treatment can save the lives of patients suffering from Covid-19.
The old generic dexamethasone was tied to a one-third reduction of deaths among ventilated patients with a one-fifth reduction in mortality among a group getting oxygen. There was no benefit for patients who did not require respiratory assistance.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
